Mia Levy

  • Vanderbilt University

    Project reveals importance of cancer gene mutation testing

    An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies. Read More

    Jun 8, 2017

  • Vanderbilt University

    VICC joins cancer genomic data sharing initiative

    Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine. Read More

    Jan 19, 2017

  • Vanderbilt University

    VICC’s Levy named Komen Scholar for breast cancer research

    Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Health Informatics and Strategy at Vanderbilt-Ingram Cancer Center (VICC), has been named a Komen Scholar by the Susan G. Komen organization. Read More

    Jun 2, 2016

  • Vanderbilt University

    Precision medicine already changing cancer treatment strategies

    The ability to test patients’ cancers for individual differences, mainly at the genetic level, and to make treatment decisions based on those differences is the hallmark of precision medicine, and Vanderbilt University Medical Center (VUMC) is among the leaders of this new approach to diagnosis and treatment. Read More

    May 26, 2016

  • Vanderbilt University

    Levy named to new VICC informatics leadership role

    Mia Levy, M.D., Ph.D., Ingram Assistant Professor of Cancer Research and director of Cancer Clinical Informatics at Vanderbilt-Ingram Cancer Center (VICC), has been named director of Cancer Health Information and Strategy, a new management post that will expand her leadership role. Read More

    Nov 19, 2015

  • My Cancer Genome launches new mobile app

    My Cancer Genome launches new mobile app

    My Cancer Genome, an online precision cancer medicine tool developed by researchers at Vanderbilt-Ingram Cancer Center, has unveiled an updated free mobile app that provides even more information about genetic alterations in various types of cancer and the therapies available to treat those alterations. Read More

    May 29, 2014

  • Vanderbilt University

    Agreement sets stage for enhanced My Cancer Genome

    Vanderbilt-Ingram Cancer Center (VICC) and GenomOncology have announced an agreement for the exclusive commercial development of a decision support tool based on My Cancer Genome, an online precision cancer medicine knowledge resource for physicians, patients, caregivers and researchers. Read More

    Feb 13, 2014

  • genetic sequence

    Vanderbilt cancer investigators win two national GE cancer research grants

    Vanderbilt-Ingram Cancer Center investigators have won two of the five global innovation grants awarded by the “GE Healthymagination Cancer Challenge.” Read More

    Mar 28, 2012

  • Vanderbilt University

    Promise of Discovery campaign adds video chat, new story lines

    Dr. Emily Kurtz (left) of the Vanderbilt Heart and Vascular Institute appears in new ads for the Promise of Discovery campaign. (Vanderbilt University) Vanderbilt University Medical Center’s award-winning “Promise of Discovery” initiative continues with the creation of additional story lines and the launch of a new series… Read More

    Oct 21, 2011

  • Vanderbilt University

    Vanderbilt: Laboratory for health care reform

    Vanderbilt University Medical Center is a laboratory for health care reform. Increasingly, Vanderbilt researchers are applying their expertise in informatics, genomics, drug discovery, basic science and clinical medicine to the solution of critical problems in patient care. Bedside checklists and electronic “dashboards” developed at Vanderbilt, for example, enable doctors and… Read More

    Apr 15, 2011

  • (iStock Photo)

    Vanderbilt-Ingram Cancer Center launches online genetic research tool

    A new online tool enables cancer patients and researchers to track the latest developments in personalized cancer medicine and connect with clinical research trials. Read More

    Mar 3, 2011